Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

ecancermedicalscience

Please Note: The journal will be closed for new submissions from Mon Jun 15th 2026 for approximately 2 months to enable us to catch up with a backlog due to record numbers in recent months.

ecancermedicalscience is an open access cancer journal focused on under-resourced communities. In order to help reduce global inequalities in cancer care and treatment, we provide free access to all articles from the point of publication and we only charge authors who have specific funding to cover publication costs.

The journal considers articles on all aspects of research relating to cancer, including molecular biology, genetics, pathophysiology, epidemiology, clinical reports, controlled trials (in particular if they are independent or publicly funded trials), health systems, cancer policy and regulatory aspects of cancer care.

Editor-in-Chief: Dr Enrique Soto Pérez de Celis MD, PhD, FASCO

ISSN: 1754-6605

NB:

  • The journal does not accept case reports
  • From 6 April 2026 APCs will apply to manuscripts submitted from countries classified as upper-middle-income or high-income.
  • Manuscripts may be declined after 60 days if suitable reviewers cannot be secured, to minimise delays and allow authors to submit their work elsewhere.
Articles
Editorials
Special issues
Author interviews
686-close-cooperation-with-health-technology-assessment-expertise-is-crucial-for-implementation-and-ultimately-reimbursement-of-innovations-in-oncology
WH van Harten, VP Retèl
685-health-technology-assessment-and-value-the-cancer-value-label-cavala-methodology
Francisco Rocha-Gonçalves, Marina Borges, Patrícia Redondo, José Laranja-Pontes
684-next-generation-sequencing-in-nsclc-and-melanoma-patients-a-cost-and-budget-impact-analysis
Rosa A van Amerongen, Valesca P Retèl, Veerle MH Coupé, Petra M Nederlof, Maartje J Vogel, Wim H van Harten
683-innovations-that-reach-the-patient-early-health-technology-assessment-and-improving-the-chances-of-coverage-and-implementation
WH van Harten, VP Retèl
682-comparison-between-standard-and-reduced-volume-radiotherapy-in-bladder-preservation-trimodality-protocol-for-muscle-invasive-bladder-cancer-patients
Waleed Arafat, Azza Darwish, George E Naoum, Wael Sameh, Gamal El Husseiny, Fathy Abd-El-Gawad, Mostafa Samir
681-phosphoethanolamine-and-the-danger-of-unproven-drugs
Noam Pondé, Evandro de Azambuja, Felipe Ades
680-repurposing-drugs-in-oncology-redo-propranolol-as-an-anti-cancer-agent
Pan Pantziarka, Gauthier Bouche, Vidula Sukhatme, Lydie Meheus, Ilse Rooman, Vikas P Sukhatme
679-prognostic-and-predictive-implications-of-sokal-euro-and-eutos-scores-in-chronic-myeloid-leukaemia-in-the-imatinib-era-experience-from-a-tertiary-oncology-centre-in-southern-india
Lakshmaiah Chinnagiriyappa Kuntegowdanahalli, Govind Babu Kanakasetty, Aditi Harsh Thanky, Lokanatha Dasappa, Linu Abraham Jacob, Suresh Babu Mallekavu, Rajeev Krishnappa Lakkavalli, Lokesh N Kadabur, Rudresha Antapura Haleshappa
678-the-first-case-of-benign-multicystic-mesothelioma-presenting-as-a-splenic-mass
Antonio D'Antonio, Carlo Baldi, Maria Addesso, Carmine Napolitano
677-veror-radiotherapy-for-low-burden-cancer-789-patients-with-957-lesions
R Orecchia, A Surgo, M Muto, A Ferrari, G Piperno, MA Gerardi, S Comi, C Garibaldi, D Ciardo, A Bazani, F Golino, F Pansini, C Fodor, P Romanelli, D Maestri, V Scroffi, S Mazza, BA Jereczek-Fossa

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation